A new report out today from cybersecurity company Miggo Security Ltd. details a now-mitigated vulnerability in Google LLC’s artificial intelligence ecosystem that allowed for a natural-language prompt ...

The organization says cross-border trade in steel-containing products reached 410 million metric tons in 2024. In addition to keeping finished and semi-finished steel trading data, Worldsteel now ...

TOKYO, Jan 9 (Reuters) - Japan's plan to give authorities the power to order foreign investors to retroactively divest acquisitions is aimed at sheltering major firms and supply chains, though it is ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

Sovos Expands Sovi AI to Increase Speed and Accuracy of Product Tax Code Classification and Data Mapping in Indirect Tax Suite Sovi AI now automates product tax code classification, enabling faster ...

Creating simple data classes in Java traditionally required substantial boilerplate code. Consider how we would represent Java’s mascots, Duke and Juggy: public class JavaMascot { private final String ...

Google shared a study of Gemini’s environmental impact, but it omits some key data. Google shared a study of Gemini’s environmental impact, but it omits some key data. is a senior science reporter ...

The last time I wrote about Recursion Pharmaceuticals (RXRX), it was with respect to a Seeking Alpha article entitled "Recursion: CDK7 Differentiation Is Initially Paying Off." With respect to this ...

In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...

Today, a brief rundown of news involving Insmed and Recursion Pharmaceuticals, as well as updates from Odyssey Therapeutics, Gilead Sciences and Novo Nordisk that you may have missed. Against the ...